相似文献
1
Malonyl-CoA: the regulator of fatty acid synthesis and oxidation.
J Clin Invest. 2012 Jun;122(6):1958-9. doi: 10.1172/jci63967.
2
Regulation of fatty acid synthesis and malonyl-CoA content in mouse brown adipose tissue in response to cold-exposure, starvation or re-feeding.
Biochem J. 1987 Apr 15;243(2):437-42. doi: 10.1042/bj2430437.
3
The role of malonyl-coa in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes.
J Biol Chem. 1978 Nov 25;253(22):8294-300.
4
Malonyl CoA control of fatty acid oxidation in the ischemic heart.
J Mol Cell Cardiol. 2002 Sep;34(9):1099-109. doi: 10.1006/jmcc.2002.2060.
5
Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Circ Res. 2004 May 14;94(9):e78-84. doi: 10.1161/01.RES.0000129255.19569.8f. Epub 2004 Apr 22.
6
Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Am J Physiol Endocrinol Metab. 2000 Aug;279(2):E259-65. doi: 10.1152/ajpendo.2000.279.2.E259.
7
Effects of exogenous fatty acid concentration on glucagon-induced changes in hepatic fatty acid metabolism.
Diabetes. 1980 Mar;29(3):236-40. doi: 10.2337/diab.29.3.236.
8
Rapid switch of hepatic fatty acid metabolism from oxidation to esterification during diurnal feeding of meal-fed rats correlates with changes in the properties of acetyl-CoA carboxylase, but not of carnitine palmitoyltransferase I.
Biochem J. 1993 Apr 1;291 ( Pt 1)(Pt 1):241-6. doi: 10.1042/bj2910241.
9
The role of the carnitine system in human metabolism.
Ann N Y Acad Sci. 2004 Nov;1033:1-16. doi: 10.1196/annals.1320.001.
10
Decreased hepatic fatty acid oxidation at weaning in the rat is not linked to a variation of malonyl-CoA concentration.
J Biol Chem. 1988 Mar 5;263(7):3284-9.
引用本文的文献
1
Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges.
Front Physiol. 2025 Aug 6;16:1623500. doi: 10.3389/fphys.2025.1623500. eCollection 2025.
2
High fat diet obesity exacerbates acute lung injury induced dysregulation of fatty acid oxidation in alveolar epithelial type 2 cells.
Am J Physiol Lung Cell Mol Physiol. 2025 Jul 22. doi: 10.1152/ajplung.00406.2024.
3
Loss of STARD7 Triggers Metabolic Reprogramming and Cell Cycle Arrest in Breast Cancer.
Adv Sci (Weinh). 2025 Aug;12(31):e03022. doi: 10.1002/advs.202503022. Epub 2025 May 30.
4
Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential.
Int J Cardiol Heart Vasc. 2025 Apr 4;58:101675. doi: 10.1016/j.ijcha.2025.101675. eCollection 2025 Jun.
5
Molecular Targets and Small Molecules Modulating Acetyl Coenzyme A in Physiology and Diseases.
ACS Pharmacol Transl Sci. 2024 Dec 18;8(1):36-46. doi: 10.1021/acsptsci.4c00476. eCollection 2025 Jan 10.
6
Loss of protects against MASLD alone or with alcohol intake by preserving lipid homeostasis.
JHEP Rep. 2024 Oct 5;7(1):101230. doi: 10.1016/j.jhepr.2024.101230. eCollection 2025 Jan.
7
Mitochondrial quality control in alcohol-associated liver disease.
Hepatol Commun. 2024 Oct 24;8(11). doi: 10.1097/HC9.0000000000000534. eCollection 2024 Nov 1.
8
Hepatocellular carcinoma cells induce γδ T cells through metabolic reprogramming into tumor-progressive subpopulation.
Front Oncol. 2024 Sep 6;14:1451650. doi: 10.3389/fonc.2024.1451650. eCollection 2024.
9
Atf3-mediated metabolic reprogramming in hepatic macrophage orchestrates metabolic dysfunction-associated steatohepatitis.
Sci Adv. 2024 Jul 26;10(30):eado3141. doi: 10.1126/sciadv.ado3141. Epub 2024 Jul 24.
10
Endogenous ethanol production in health and disease.
Nat Rev Gastroenterol Hepatol. 2024 Aug;21(8):556-571. doi: 10.1038/s41575-024-00937-w. Epub 2024 Jun 3.
本文引用的文献
1
Fuel metabolism in starvation.
Annu Rev Nutr. 2006;26:1-22. doi: 10.1146/annurev.nutr.26.061505.111258.
2
The role of the carnitine system in human metabolism.
Ann N Y Acad Sci. 2004 Nov;1033:1-16. doi: 10.1196/annals.1320.001.
3
Ketoacids? Good medicine?
Trans Am Clin Climatol Assoc. 2003;114:149-61; discussion 162-3.
4
Carnitine transport by organic cation transporters and systemic carnitine deficiency.
Mol Genet Metab. 2001 Aug;73(4):287-97. doi: 10.1006/mgme.2001.3207.
5
The metabolic derangements and treatment of diabetic ketoacidosis.
N Engl J Med. 1983 Jul 21;309(3):159-69. doi: 10.1056/NEJM198307213090307.
6
The regulation of the release of ketone bodies by the liver.
Adv Enzyme Regul. 1966;4:339-54. doi: 10.1016/0065-2571(66)90027-6.
7
8
Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase.
Diabetes Metab Rev. 1989 May;5(3):271-84. doi: 10.1002/dmr.5610050305.
9
Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon.
J Clin Invest. 1975 Jun;55(6):1202-9. doi: 10.1172/JCI108038.
10
A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.
J Clin Invest. 1977 Jul;60(1):265-70. doi: 10.1172/JCI108764.
Zotero 插件